Neurology 1609 - Neurology Alert - Sep 01, 2012

Target Audience:

This activity is intended for the neurologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing:

Physician Editor
Matthew Fink, MD
Interim Chair and Neurologist-in-Chief
Department of Neurology and Neuroscience
Weill Cornell Medical College
New York Presbyterian Hospital

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Peer Reviewer
M. Flint Beal, MD
Anne Parrish Titzel Professor
Department of Neurology and Neuroscience
Weill Cornell Medical Center

Assistant Editors
Michael Rubin, MD, FRCP(C)
Professor of Clinical Neurology;
Specialty area, Neuromuscular Disorders
Weill Cornell Medical College

Claire Henchcliffe, MD, DPhil
Associate Professor of Neurology and Neuroscience;
Specialty area, Movement Disorders

Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience
Comprehensive Epilepsy Center
Weill Cornell Medical College

Authors
Michael Lin, MD, PhD
Associate Professor of Neurology and Neurosciences
Weill Cornell Medical College

Halinder S. Mangat, MD
Assistant Professor of Clinical Neurology
Weill Cornell Medical College

Alexander Shtilbans, MD, PhD
Assistant Professor of Neurology
Weill Cornell Medical College

Subjects:

  • Can We Predict Pharmacoresistant Epilepsy?
  • Antioxidant Supplements Are Not of Proven Benefit for Alzheimer's Disease
  • Alternate Day Steroids for Polymyositis
  • Frontostriatal Network Under-recruitment Underlies Mild Cognitive Impairment in Parkinson's Disease
  • More Than Just a Number: Complexity of Intracranial Pressure Correlates with Outcome After Traumatic Brain Injury
  • Mesenchymal Stem Cells Therapy for Multiple System Atrophy

Objectives:

  • discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • discuss the pathogenesis and treatment of pain
  • describe the basic science of brain function
  • discuss new information regarding new drugs for commonly diagnosed neurological conditions and new uses for traditional drugs
  • identify nonclinical issues of importance for the neurologist.

Financial Disclosure:

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for MAQUET. Assistant editors Michael Rubin, MD, FRCP(C) and Padmaja Kandula, MD, authors Michael Lin, MD, PhD, Halinder S. Mangat, MD and Alexander Shtilbans, MD, PhD, peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Assistant Editor Claire Henchcliffe, MD, DPhil reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmithKline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Copyright 2012 AHC Media LLC. All rights reserved.